ID   ERN1_HUMAN              Reviewed;         977 AA.
AC   O75460; A1L457; A8K8N8; A8MXS7; Q59EE2;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 2.
DT   02-NOV-2010, entry version 100.
DE   RecName: Full=Serine/threonine-protein kinase/endoribonuclease IRE1;
DE   AltName: Full=Endoplasmic reticulum-to-nucleus signaling 1;
DE   AltName: Full=Inositol-requiring protein 1;
DE            Short=hIRE1p;
DE   AltName: Full=Ire1-alpha;
DE            Short=IRE1a;
DE   Includes:
DE     RecName: Full=Serine/threonine-protein kinase;
DE              EC=2.7.11.1;
DE   Includes:
DE     RecName: Full=Endoribonuclease;
DE              EC=3.1.26.-;
DE   Flags: Precursor;
GN   Name=ERN1; Synonyms=IRE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AUTOPHOSPHORYLATION,
RP   GLYCOSYLATION, AND MUTAGENESIS OF LYS-599.
RC   TISSUE=Liver;
RX   MEDLINE=98301437; PubMed=9637683;
RA   Tirasophon W., Welihinda A.A., Kaufman R.J.;
RT   "A stress response pathway from the endoplasmic reticulum to the
RT   nucleus requires a novel bifunctional protein kinase/endoribonuclease
RT   (Ire1p) in mammalian cells.";
RL   Genes Dev. 12:1812-1824(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endothelial cell;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 2-977 (ISOFORM 2).
RC   TISSUE=Brain, and Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH TAOK3 AND TRAF2.
RX   PubMed=11278723; DOI=10.1074/jbc.M010677200;
RA   Yoneda T., Imaizumi K., Oono K., Yui D., Gomi F., Katayama T.,
RA   Tohyama M.;
RT   "Activation of caspase-12, an endoplastic reticulum (ER) resident
RT   caspase, through tumor necrosis factor receptor-associated factor 2-
RT   dependent mechanism in response to the ER stress.";
RL   J. Biol. Chem. 276:13935-13940(2001).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF LYS-599.
RX   PubMed=11175748; DOI=10.1038/35055065;
RA   Iwawaki T., Hosoda A., Okuda T., Kamigori Y., Nomura-Furuwatari C.,
RA   Kimata Y., Tsuru A., Kohno K.;
RT   "Tranlational control by the ER transmembrane kinase/ribonuclease IRE1
RT   under ER stress.";
RL   Nat. Cell Biol. 3:158-164(2001).
RN   [9]
RP   FUNCTION, HOMODIMERIZATION, ENZYME REGULATION, INTERACTION WITH HSPA5,
RP   AND MUTAGENESIS OF CYS-109; CYS-148 AND CYS-332.
RX   MEDLINE=22625692; PubMed=12637535; DOI=10.1074/jbc.M300418200;
RA   Liu C.Y., Xu Z., Kaufman R.J.;
RT   "Structure and intermolecular interactions of the luminal dimerization
RT   domain of human IRE1alpha.";
RL   J. Biol. Chem. 278:17680-17687(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-533; SER-548; SER-551;
RP   SER-726 AND THR-973, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 24-390.
RX   PubMed=16973740; DOI=10.1073/pnas.0606480103;
RA   Zhou J., Liu C.Y., Back S.H., Clark R.L., Peisach D., Xu Z.,
RA   Kaufman R.J.;
RT   "The crystal structure of human IRE1 luminal domain reveals a
RT   conserved dimerization interface required for activation of the
RT   unfolded protein response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14343-14348(2006).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-244; MET-418; ARG-474; TRP-635;
RP   SER-700; PHE-769 AND LEU-830.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Senses unfolded proteins in the lumen of the endoplasmic
CC       reticulum via its N-terminal domain which leads to enzyme auto-
CC       activation. The active endoribonuclease domain splices XBP1 mRNA
CC       to generate a new C-terminus, converting it into a potent
CC       unfolded-protein response transcriptional activator and triggering
CC       growth arrest and apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: The kinase domain is activated by trans-
CC       autophosphorylation. Kinase activity is required for activation of
CC       the endoribonuclease domain.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Dimer formation is driven by
CC       hydrophobic interactions within the N-terminal luminal domains and
CC       stabilized by disulfide bridges. Also binds HSPA5, a negative
CC       regulator of the unfolded protein response. This interaction may
CC       disrupt homodimerization and prevent activation of ERN1. Interacts
CC       with TAOK3 and TRAF2.
CC   -!- INTERACTION:
CC       P07823:HSPA5 (xeno); NbExp=1; IntAct=EBI-371750, EBI-371776;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75460-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75460-2; Sequence=VSP_034582, VSP_034583;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. High levels observed
CC       in pancreatic tissue.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 KEN domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF059198; AAC25991.1; -; mRNA.
DR   EMBL; AK292403; BAF85092.1; -; mRNA.
DR   EMBL; DA254477; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB209869; BAD93106.1; -; mRNA.
DR   EMBL; AC005803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025362; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94214.1; -; Genomic_DNA.
DR   EMBL; BC130405; AAI30406.1; -; mRNA.
DR   EMBL; BC130407; AAI30408.1; -; mRNA.
DR   EMBL; BI912495; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00015974; -.
DR   IPI; IPI00873219; -.
DR   RefSeq; NP_001424.3; -.
DR   UniGene; Hs.133982; -.
DR   UniGene; Hs.700027; -.
DR   PDB; 2HZ6; X-ray; 3.10 A; A=24-390.
DR   PDBsum; 2HZ6; -.
DR   ProteinModelPortal; O75460; -.
DR   SMR; O75460; 566-962.
DR   IntAct; O75460; 1.
DR   MINT; MINT-3001268; -.
DR   STRING; O75460; -.
DR   PhosphoSite; O75460; -.
DR   PRIDE; O75460; -.
DR   Ensembl; ENST00000433197; ENSP00000401445; ENSG00000178607.
DR   GeneID; 2081; -.
DR   KEGG; hsa:2081; -.
DR   UCSC; uc002jdz.2; human.
DR   CTD; 2081; -.
DR   GeneCards; GC17M062120; -.
DR   H-InvDB; HIX0014084; -.
DR   HGNC; HGNC:3449; ERN1.
DR   HPA; CAB009495; -.
DR   HPA; HPA027730; -.
DR   MIM; 604033; gene.
DR   PharmGKB; PA27861; -.
DR   eggNOG; prNOG10059; -.
DR   HOGENOM; HBG355600; -.
DR   HOVERGEN; HBG051506; -.
DR   InParanoid; O75460; -.
DR   OMA; RYFTSRF; -.
DR   OrthoDB; EOG9KWNCK; -.
DR   PhylomeDB; O75460; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_15380; Diabetes pathways.
DR   NextBio; 8459; -.
DR   ArrayExpress; O75460; -.
DR   Bgee; O75460; -.
DR   CleanEx; HS_ERN1; -.
DR   Genevestigator; O75460; -.
DR   GermOnline; ENSG00000178607; Homo sapiens.
DR   GO; GO:0030176; C:integral to endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016891; F:endoribonuclease activity, producing 5'-pho...; IEA:InterPro.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006987; P:activation of signaling protein activity in...; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0007050; P:cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0006917; P:induction of apoptosis; ISS:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.
DR   GO; GO:0045449; P:regulation of transcription; IEA:UniProtKB-KW.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR010513; KEN_RNase_activator.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR018391; PQQ_beta_propeller_repeat.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR006567; PUG-dom.
DR   InterPro; IPR011047; Quino_AlcDH-like.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Gene3D; G3DSA:2.140.10.10; Quinoprotein_alc_DH-like; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF06479; Ribonuc_2-5A; 1.
DR   SMART; SM00564; PQQ; 5.
DR   SMART; SM00580; PUG; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50998; Quin_alc_DH_like; 1.
DR   PROSITE; PS51392; KEN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Hydrolase; Kinase; Magnesium; Membrane; Metal-binding;
KW   Multifunctional enzyme; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Signal; Transcription;
KW   Transcription regulation; Transferase; Transmembrane;
KW   Transmembrane helix; Unfolded protein response.
FT   SIGNAL        1     18       Potential.
FT   CHAIN        19    977       Serine/threonine-protein
FT                                kinase/endoribonuclease IRE1.
FT                                /FTId=PRO_0000024327.
FT   TOPO_DOM     19    443       Lumenal (Potential).
FT   TRANSMEM    444    464       Helical; (Potential).
FT   TOPO_DOM    465    977       Cytoplasmic (Potential).
FT   DOMAIN      571    832       Protein kinase.
FT   DOMAIN      835    963       KEN.
FT   NP_BIND     577    585       ATP (By similarity).
FT   ACT_SITE    688    688       Proton acceptor (By similarity).
FT   BINDING     599    599       ATP.
FT   MOD_RES     533    533       Phosphoserine.
FT   MOD_RES     548    548       Phosphoserine.
FT   MOD_RES     551    551       Phosphoserine.
FT   MOD_RES     726    726       Phosphoserine.
FT   MOD_RES     973    973       Phosphothreonine.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ      19     70       IFGSTSTVTLPETLLFVSTLDGSLHAVSKRTGSIKWTLKED
FT                                PVLQVPTHVEE -> VSDRGAWGGGQLATAGSGPGQRRGAG
FT                                AGVRAGSATAAARCPVSPAVGGSGRA (in isoform
FT                                2).
FT                                /FTId=VSP_034582.
FT   VAR_SEQ      71    977       Missing (in isoform 2).
FT                                /FTId=VSP_034583.
FT   VARIANT     244    244       N -> S (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040488.
FT   VARIANT     418    418       V -> M (in dbSNP:rs55869215).
FT                                /FTId=VAR_040489.
FT   VARIANT     474    474       L -> R (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040490.
FT   VARIANT     635    635       R -> W (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040491.
FT   VARIANT     700    700       N -> S.
FT                                /FTId=VAR_040492.
FT   VARIANT     769    769       S -> F (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040493.
FT   VARIANT     830    830       P -> L (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040494.
FT   MUTAGEN     109    109       C->S: No effect on dimerization.
FT   MUTAGEN     148    148       C->S: No effect on dimerization. Weakens
FT                                dimer; when associated with S-148.
FT   MUTAGEN     332    332       C->S: No effect on dimerization. Weakens
FT                                dimer; when associated with S-332.
FT   MUTAGEN     599    599       K->A: Loss of autophosphorylation and of
FT                                endoribonuclease activity. Inhibition of
FT                                growth arrest.
FT   CONFLICT    190    191       DV -> EG (in Ref. 1; AAC25991).
FT   CONFLICT    768    768       I -> V (in Ref. 1; AAC25991).
FT   CONFLICT    816    816       D -> G (in Ref. 2; BAF85092).
FT   CONFLICT    824    825       KH -> ND (in Ref. 1; AAC25991).
FT   CONFLICT    880    880       V -> D (in Ref. 1; AAC25991).
FT   CONFLICT    904    904       M -> T (in Ref. 2; BAF85092).
FT   CONFLICT    924    924       S -> T (in Ref. 1; AAC25991).
FT   STRAND       32     37
FT   STRAND       40     46
FT   TURN         47     49
FT   STRAND       52     57
FT   STRAND       73     75
FT   TURN         77     79
FT   STRAND       82     84
FT   STRAND       93     95
FT   HELIX       100    104
FT   STRAND      120    128
FT   STRAND      154    164
FT   STRAND      168    172
FT   STRAND      176    182
FT   STRAND      197    201
FT   STRAND      205    209
FT   TURN        211    213
FT   STRAND      216    221
FT   STRAND      226    231
FT   STRAND      238    240
FT   STRAND      243    246
FT   HELIX       247    264
FT   HELIX       273    279
FT   STRAND      280    284
FT   STRAND      286    288
FT   STRAND      297    300
FT   TURN        359    361
SQ   SEQUENCE   977 AA;  109735 MW;  A2DF808CCE015536 CRC64;
     MPARRLLLLL TLLLPGLGIF GSTSTVTLPE TLLFVSTLDG SLHAVSKRTG SIKWTLKEDP
     VLQVPTHVEE PAFLPDPNDG SLYTLGSKNN EGLTKLPFTI PELVQASPCR SSDGILYMGK
     KQDIWYVIDL LTGEKQQTLS SAFADSLCPS TSLLYLGRTE YTITMYDTKT RELRWNATYF
     DYAASLPEDD VDYKMSHFVS NGDGLVVTVD SESGDVLWIQ NYASPVVAFY VWQREGLRKV
     MHINVAVETL RYLTFMSGEV GRITKWKYPF PKETEAKSKL TPTLYVGKYS TSLYASPSMV
     HEGVAVVPRG STLPLLEGPQ TDGVTIGDKG ECVITPSTDV KFDPGLKSKN KLNYLRNYWL
     LIGHHETPLS ASTKMLERFP NNLPKHRENV IPADSEKKSF EEVINLVDQT SENAPTTVSR
     DVEEKPAHAP ARPEAPVDSM LKDMATIILS TFLLIGWVAF IITYPLSMHQ QQQLQHQQFQ
     KELEKIQLLQ QQQQQLPFHP PGDTAQDGEL LDTSGPYSES SGTSSPSTSP RASNHSLCSG
     SSASKAGSSP SLEQDDGDEE TSVVIVGKIS FCPKDVLGHG AEGTIVYRGM FDNRDVAVKR
     ILPECFSFAD REVQLLRESD EHPNVIRYFC TEKDRQFQYI AIELCAATLQ EYVEQKDFAH
     LGLEPITLLQ QTTSGLAHLH SLNIVHRDLK PHNILISMPN AHGKIKAMIS DFGLCKKLAV
     GRHSFSRRSG VPGTEGWIAP EMLSEDCKEN PTYTVDIFSA GCVFYYVISE GSHPFGKSLQ
     RQANILLGAC SLDCLHPEKH EDVIARELIE KMIAMDPQKR PSAKHVLKHP FFWSLEKQLQ
     FFQDVSDRIE KESLDGPIVK QLERGGRAVV KMDWRENITV PLQTDLRKFR TYKGGSVRDL
     LRAMRNKKHH YRELPAEVRE TLGSLPDDFV CYFTSRFPHL LAHTYRAMEL CSHERLFQPY
     YFHEPPEPQP PVTPDAL
//
